Arcus Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Arcus Biosciences is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-1.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 31.00M	$ 32.00M	$ 29.00M	$ 25.00M	$ 33.66M
Gross Profit	$ 31.00M	$ 32.00M	$ 29.00M	$ 25.00M	$ 33.66M
EBIT	$ -82.00M	$ -69.00M	$ -74.00M	$ -78.00M	$ -74.44M
EBITDA	$ -82.00M	$ -71.00M	$ -74.00M	$ -78.00M	$ -73.02M
Net Income Common Stockholders	$ -81.00M	$ -71.00M	$ -75.00M	$ -80.00M	$ -67.46M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 759.00M	$ 799.00M	$ 930.00M	$ 954.00M	$ 1.01B
Total Assets	$ 1.09B	$ 1.19B	$ 1.22B	$ 1.25B	$ 1.34B
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -759.00M	$ -799.00M	$ -930.00M	$ -954.00M	$ -1.01B
Total Liabilities	$ 633.00M	$ 671.00M	$ 654.00M	$ 654.00M	$ 688.00M
Stockholders Equity	$ 462.00M	$ 520.00M	$ 566.00M	$ 600.00M	$ 657.00M
Cash Flow	-
Free Cash Flow	$ -94.00M	$ -73.00M	$ -62.00M	$ -101.00M	$ -70.12M
Operating Cash Flow	$ -88.00M	$ -63.00M	$ -57.00M	$ -98.00M	$ -69.74M
Investing Cash Flow	$ 28.00M	$ 11.00M	$ 26.00M	$ 129.00M	$ 46.81M
Financing Cash Flow	$ 3.00M	$ 6.00M	$ 23.00M	$ 1.00M	$ 11.20M

Currency in USD

Arcus Biosciences Earnings and Revenue History

Income Statement >

Arcus Biosciences Debt to Assets

Balance Sheet >

Arcus Biosciences Cash Flow

Cash Flow >

Arcus Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing